Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis
Palmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …
Continue reading "Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis"